This suggests that BP-CML may be facilitated by pre-leukemic lesions than precede the acquisition of BCR-ABL – particularly in cases where patients present with BP at diagnosis. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.